EXD2: A new regulator of mitochondrial translation and potential target for cancer therapy

被引:1
|
作者
Stracker, Travis H. [1 ]
机构
[1] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain
来源
MOLECULAR & CELLULAR ONCOLOGY | 2018年 / 5卷 / 03期
关键词
EXD2; mitochondria; metabolic reprogramming; metformin; cancer metabolism; translation; glutamine; Biology of malignant cells; Cancer stem cells; Mode of action of anticancer agents; Tumor metabolism;
D O I
10.1080/23723556.2018.1445943
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent work we identified Exonuclease 3'-5' domain-containing protein 2 (EXD2) as an RNase required for efficient mitochondrial translation. Here I describe in brief the cellular phenotypes caused by EXD2 deficiency and make the case that EXD2 inhibitors could be valuable agents for cancer therapy.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer Therapy
    Lu, Weiqin
    Hu, Yumin
    Chen, Gang
    Chen, Zhao
    Zhang, Hui
    Wang, Feng
    Feng, Li
    Pelicano, Helene
    Wang, Hua
    Keating, Michael J.
    Liu, Jinsong
    McKeehan, Wallace
    Wang, Huamin
    Luo, Yongde
    Huang, Peng
    PLOS BIOLOGY, 2012, 10 (05):
  • [32] Cancer stem cells: a potential target for cancer therapy
    Hong Qiu
    Xiaoguang Fang
    Qi Luo
    Gaoliang Ouyang
    Cellular and Molecular Life Sciences, 2015, 72 : 3411 - 3424
  • [33] Cancer stem cells: a potential target for cancer therapy
    Qiu, Hong
    Fang, Xiaoguang
    Luo, Qi
    Ouyang, Gaoliang
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (18) : 3411 - 3424
  • [34] Eotaxin-2 and colorectal cancer: A potential target for immune therapy
    Cheadle, Eleanor J.
    Riyad, Kallingal
    Subar, Daren
    Rothwell, Dominic G.
    Ashton, Garry
    Batha, Hayley
    Sherlock, David J.
    Hawkins, Robert E.
    Gilham, David E.
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5719 - 5728
  • [35] B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy
    Alam, Manzar
    Ali, Sabeeha
    Mohammad, Taj
    Hasan, Gulam Mustafa
    Yadav, Dharmendra Kumar
    Hassan, Md. Imtaiyaz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [36] P2X7 receptor: a critical regulator and potential target for breast cancer
    Zhu, Xiaodi
    Li, Qianqian
    Song, Wei
    Peng, Xiaoxiang
    Zhao, Ronglan
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (03): : 349 - 358
  • [37] P2X7 receptor: a critical regulator and potential target for breast cancer
    Xiaodi Zhu
    Qianqian Li
    Wei Song
    Xiaoxiang Peng
    Ronglan Zhao
    Journal of Molecular Medicine, 2021, 99 : 349 - 358
  • [38] SIK2: A critical glucolipid metabolic reprogramming regulator and potential target in ovarian cancer
    Hu, Dan
    Du, JunHong
    Xing, YiJuan
    Cheng, YueMei
    He, RuiFen
    Liang, XiaoLei
    Li, HongLi
    Yang, YongXiu
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (08) : 2000 - 2009
  • [39] (TA)MUC1 as a potential new target for breast cancer therapy
    Heimes, A. S.
    Fries, P.
    Stergiou, N.
    Attariya, R.
    Hasenburg, A.
    Schmidt, M.
    Schmitt, E.
    Brenner, W.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E213 - E213
  • [40] Potential new target for cancer found
    不详
    MOLECULAR THERAPY, 2007, 15 (09) : 1575 - 1575